Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-22-003285

← back to feed
Filed
May 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Sga Expense Q3 2022 · Sep 30, 2022 $771K
Sga Expense Q3 2022 · Sep 30, 2021 $740K
Sga Expense Q3 2022 · Mar 31, 2021 $245K
Rd Expense Q3 2022 · Sep 30, 2022 $4.12M
Rd Expense Q3 2022 · Sep 30, 2021 $4.92M
Rd Expense Q3 2022 · Mar 31, 2021 $1.42M
Net Income Q3 2022 · Sep 30, 2022 −$5.42M
Net Income Q3 2022 · Sep 30, 2021 −$11.31M
Net Income Q3 2022 · Mar 31, 2021 −$3.96M
Net Income Q3 2022 · Mar 31, 2021 −$11.31M
Net Income Q3 2022 · Dec 31, 2020 −$6.17M
Net Income Q3 2022 · Sep 30, 2020 −$1.17M
Operating Income Q3 2022 · Sep 30, 2022 −$5.5M
Operating Income Q3 2022 · Sep 30, 2021 −$6.49M
Operating Income Q3 2022 · Mar 31, 2021 −$1.92M
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Mar 31, 2021 $0
Revenue Q3 2022 · Jul 31, 2019 $400K
Shares Outstanding Q3 2022 · May 11, 2022 456.58M sh
Cash And Equivalents Q3 2022 · Mar 31, 2022 $8.8M
Cash And Equivalents Q3 2022 · Jun 30, 2021 $10.19M
Cash And Equivalents Q3 2022 · Mar 31, 2021 $13.01M
Cash And Equivalents Q3 2022 · Jun 30, 2020 $6.02M
Current Liabilities Q3 2022 · Mar 31, 2022 $4.59M
Current Liabilities Q3 2022 · Jun 30, 2021 $6.54M
Total Liabilities Q3 2022 · Mar 31, 2022 $5.84M
Total Liabilities Q3 2022 · Jun 30, 2021 $6.79M
Current Assets Q3 2022 · Mar 31, 2022 $8.82M
Current Assets Q3 2022 · Jun 30, 2021 $10.69M
Total Assets Q3 2022 · Mar 31, 2022 $11.66M
Total Assets Q3 2022 · Jun 30, 2021 $14.3M
Operating Cash Flow Q3 2022 · Mar 31, 2021 −$6.89M
Stockholders Equity Q3 2022 · Mar 31, 2021 $10.21M
Stockholders Equity Q3 2022 · Dec 31, 2020 $3.44M
Stockholders Equity Q3 2022 · Sep 30, 2020 $4.67M
Stockholders Equity Q3 2022 · Jun 30, 2020 $1.46M